Skip to main content

Table 5 Treatment regimens for all 13 patients with npAIR with time of symptom onset to initiation of treatments

From: Non-paraneoplastic autoimmune retinopathy: multimodal testing characteristics of 13 cases

Patient

Affected eye

Treatment

Time from symptom onset to treatment

1

OU

Observation

n/a

2

OS

Observation

n/a

3

OS

Mycophenolate mofetil 500 mg BID, switched to azathioprine 200 mg

7 years

4

OU

Observation

n/a

5

OU

Valacyclovir 3 g daily 1 week, 1 g daily 21 days

2 years

6

OD

Beta carotene 25,000 IU, vitamin E 400 IU, lutein 20 mg, CoQ10 300 mg BID, mycophenolate mofetil 1000 mg BID

9 years

7

OS

Observation

n/a

8

OS

Observation

n/a

9

OU

Observation

n/a

10

OS

Mycophenolate mofetil 500 mg

6 years

11

OD

Observation

n/a

12

OD

Observation

n/a

13

OU

Rituximab (2 doses, 1 g), IV methylprednisolone (2 doses) followed by oral prednisone taper

41 years